Novavax, Inc. - Special Call Transcript
Ladies and gentlemen, thank you for standing by, and welcome to the Novavax NanoFlu achieves all primary endpoints in the Phase III clinical trials conference call. (Operator Instructions)
I would now like to introduce your host for today's conference call, Ms. Erika Trahan, Senior Manager of Investor Relations and Public Relations. You may begin.
Thank you, operator. Good morning. I'd like to thank everyone who has joined today's call to discuss our Phase III NanoFlu results. A press release announcing our results is currently available on our website at novavax.com, and an audio archive of this conference call will be available on our website later today.
Joining me on today's call are Stan Erck, President and CEO of Novavax; John Trizzino, Chief Business Officer and Chief Financial Officer; and Dr. Gregory Glenn, our President of Research and Development, will be available for the Q&A portion of the call.
Before we begin with prepared remarks,
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
